LFCR Q1 2021 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

Q1 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$136M-2.2% YoY

Gross Profit

$16M12.1% margin

Operating Income

-$12M-9.2% margin

Net Income

-$11M-8.1% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

-13.1%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$12M

Stock-Based Comp.

$892,000

Balance Sheet

Total Assets

$506M

Total Liabilities

$285M

Stockholders' Equity

$221M

Cash & Equivalents

$589,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$136M	$139M	-2.2%
Gross Profit	$16M	$15M	+6.6%
Operating Income	-$12M	-$4M	-184.7%
Net Income	-$11M	-$5M	-129.9%